Skip to main content
. 2022 Oct 19;9:922431. doi: 10.3389/fmed.2022.922431

TABLE 1.

Baseline characteristics of patients.

Patients (N = 34)
Age, mean ± SD, year 31.8 ± 9.0
Male, no (%) 21 (61.8)
Comorbidity, no (%)
Diabetes 1 (2.9)
Hypertension 1 (2.9)
Asthma 1 (2.9)
Depression 3 (8.8)
Patient classification by symptom
Symptomatic 32 (94.1)
Presymptomatic 2 (5.9)
Asymptomatic 0 (0)
Symptoms at admission
Fever 26 (76.5)
Chill 9 (26.5)
Cough 17 (50.0)
Sputum 5 (14.7)
Sore throat 17 (50.0)
Dyspnea 1 (2.9)
Rhinorrhea 4 (11.8)
Nasal stuffiness 4 (11.8)
Myalgia 17 (50.0)
Headache 9 (26.5)
Loss of taste 1 (2.9)
Loss of smell 4 (11.8)
Diarrhea 1 (2.9)
Days from symptom onset to admission*, median (range) 2 (0–8)
Days from COVID-19 diagnosis to admission*, median (range) 1 (0–2)
Days from symptom onset to first RAT test, median (IQR) 5 (4–6)
Days from admission to first RAT test, median (IQR) 3 (3–3)
Median days from admission to discharge, no. (range) 10 (5–14)
Mean viral load at diagnosis, Ct value (E gene)† 18.2
Infiltrations on chest x-ray at admission, no (%) 1 (2.9)
Delta variant (%)
Yes 25 (73.5)
No 9 (26.5)

IQR, interquartile range. *Admission indicates admission to a community treatment center for isolation purposes. †Initial viral load at the time of diagnosis (one missing).